If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCurrys Regulatory News (CURY)

Share Price Information for Currys (CURY)

Share Price is delayed by 15 minutes
Get Live Data
159.20    -2.20 (-1.36%)
Bid:
158.70
Ask:
159.10
Spread: 0.40 (0.252%)
Market Cap: £1.65b
CURY Live PriceLast checked at - London Stock Exchange

Intraday Currys Share Chart

Director/PDMR Shareholding

12 Aug 2025 14:41

RNS Number : 0382V
Currys PLC
12 August 2025
 

12 August 2025

CURRYS PLC

NOTIFICATION OF TRANSACTION OF DIRECTOR

Award under the 2022/23 Deferred Share Bonus Plan ("DSBP")

In accordance with the requirements of DTR 3.1 and Market Abuse Regulation Article 19, Currys plc (the 'Company') announces the following share transaction undertaken by Alex Baldock, Group Chief Executive (a PDMR).

Alex Baldock exercised nil cost options over ordinary shares of 0.1 pence in the Company in respect of the 2022/23 DSBP Award (the "Award") which was granted on the 3 August 2023 under the DSBP. The Award vested on 3 August 2025, and Alex subsequently exercised a total of 288,617 options and sold 136,128 shares to cover the tax liability arising on the transaction. The remaining 152,489 shares were retained.

PMDR DEALING NOTIFICATION

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Alex Baldock

2

Reason for the notification

a)

Position/status

Group Chief Executive

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer

a)

Name

Currys plc

b)

LEI

2138001E12GWLLDQQF16

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Ordinary shares of 0.1p each in Currys plc

Identification code

GB00B4Y7R145

b)

Nature of the transaction

Exercise of a share option under the Currys Deferred Share Bonus Plan and sale of shares to cover the tax and NIC arising from the exercise.

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Nil cost

288,617

£1.131

136,128

 

 

d)

Aggregated information

-

Aggregated volume

-

Price

1. Exercise

Price(s)

Volume(s)

Total

Nil cost

288,617

 £0.00

 

2. Sale

Price(s)

Volume(s)

Total

£1.131

136,128

 £153,961

e)

Date of the transaction

(DD-MM-YYYY)

12-08-2025

f)

Place of the transaction

London Stock Exchange (XLON)

 

Enquiries:

 

Sarah Thomas Deputy Company Secretary +44 (0)7401 373 188

 

Dan Homan Investor Relations Director +44 (0)7401 400 442

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBXGDIGSBDGUD
Date   Source Headline
3rd May 20235:21 pmRNSHolding(s) in Company
2nd May 202311:43 amRNSTotal Voting Rights
11th Apr 20235:53 pmRNSHolding(s) in Company
5th Apr 202310:30 amRNSDirector/PDMR Shareholding
3rd Apr 202311:08 amRNSTotal Voting Rights
20th Mar 20235:02 pmRNSHolding(s) in Company
16th Mar 20237:00 amRNSNew leadership appointed in Nordics
9th Mar 202311:32 amRNSDirectorate Change
9th Mar 202311:28 amRNSDirector Declaration
6th Mar 202311:05 amRNS2022 AGM Results - update statement
2nd Mar 202312:11 pmRNSHolding(s) in Company
1st Mar 20239:19 amRNSTotal Voting Rights
6th Feb 202311:13 amRNSDirector Declaration
1st Feb 20239:44 amRNSTotal Voting Rights
18th Jan 20237:00 amRNSPeak trading - UK&I continues to strengthen
3rd Jan 20238:41 amRNSTotal Voting Rights
15th Dec 20227:00 amRNSCurrys plc - Interim results
1st Dec 202210:51 amRNSTotal Voting Rights
17th Nov 20224:03 pmRNSHolding(s) in Company
1st Nov 20229:48 amRNSTotal Voting Rights
27th Oct 20227:00 amRNSAppointment of Joint Corporate Broker
26th Oct 202211:04 amRNSBoard committees
17th Oct 20221:48 pmRNSHolding(s) in Company
6th Oct 202210:34 amRNSDirector/PDMR Shareholding
3rd Oct 20229:46 amRNSTotal Voting Rights
8th Sep 20223:30 pmRNSResult of AGM
1st Sep 202212:51 pmRNSTotal Voting Rights
30th Aug 20227:00 amRNSDirector/PDMR Shareholding
24th Aug 202210:00 amRNSHolding(s) in Company
9th Aug 20229:28 amRNSAnnual Financial Report
1st Aug 20229:44 amRNSTotal Voting Rights
26th Jul 20221:43 pmRNSDirector/PDMR Shareholding
25th Jul 20222:58 pmRNSDirector/PDMR Shareholding
7th Jul 20227:00 amRNSCurrys - Full Year Results 2021/22
6th Jul 20227:13 amRNSDirector Declaration
1st Jul 20229:14 amRNSTotal Voting Rights
23rd Jun 20222:23 pmRNSHolding(s) in Company
1st Jun 20229:54 amRNSTotal Voting Rights
24th May 20229:51 amRNSHolding(s) in Company
19th May 20227:00 amRNSDirectorate Change
10th May 202210:19 amRNSHolding(s) in Company
10th May 202210:15 amRNSHolding(s) in Company
3rd May 20221:41 pmRNSTotal Voting Rights
5th Apr 20223:36 pmRNSDirector/PDMR Shareholding
1st Apr 202210:27 amRNSTotal Voting Rights
30th Mar 20221:52 pmRNSHolding(s) in Company
11th Mar 20225:28 pmRNSTransaction in Own Shares
10th Mar 20225:13 pmRNSTransaction in Own Shares
9th Mar 20225:24 pmRNSTransaction in Own Shares
8th Mar 20225:14 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.